Be Prepared to Treat and Prevent VTE Due to Cancer

Recent guideline changes will raise questions about how to treat and prevent cancer-associated venous thromboembolism (VTE).

Be prepared to manage these patients...and help avoid errors.

Treatment. For years, we've been using a low-molecular-weight heparin (LMWH), such as enoxaparin, for most patients with cancer.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals